Legal Representation
Attorney
Christina Brown
USPTO Deadlines
Application History
36 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Sep 15, 2025 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Sep 15, 2025 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Feb 4, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Feb 3, 2025 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Feb 3, 2025 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Feb 3, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Aug 13, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Aug 13, 2024 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Aug 13, 2024 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Aug 13, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Feb 9, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Feb 8, 2024 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Feb 8, 2024 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Feb 8, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Aug 15, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jun 20, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jun 20, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| May 31, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| May 12, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| May 9, 2023 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| May 9, 2023 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| May 9, 2023 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| May 9, 2023 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Nov 16, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Nov 16, 2022 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| Nov 16, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Oct 6, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Oct 6, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Oct 6, 2022 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Aug 30, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Apr 7, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Apr 7, 2022 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Apr 7, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Mar 24, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Oct 27, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Oct 1, 2021 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
House mark for pharmaceutical compositions as prophylaxis, diagnostics or treatments for human and animal disease and illness, namely infectious diseases, inflammatory disorders, respiratory diseases, cardiovascular diseases, autoimmune disorders, gastrointestinal disorders, cancer, hematological diseases, neurological diseases, hepatic diseases, renal diseases, lymphatic disorders, metabolic disorders, genetic disorders, dermatological disorders, ocular diseases, and orphan diseases and drug delivery agents and formulations consisting of compounds that facilitate the delivery of a wide range of pharmaceuticals and other chemical, synthetic or biologic payloads, in the nature of pharmaceutical compositions to treat the above disorders that can be administered in a range of approaches
Class 042
research and development in the pharmaceutical, biotechnology, and digital medicine fields
Classification
International Classes
005
042